Surveillance of Low-Grade Appendiceal Mucinous Neoplasms With Peritoneal Metastases After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Are 5 Years Enough? A Multisite Experience

[1]  A. Lowy,et al.  Histologic Predictors of Recurrence in Mucinous Appendiceal Tumors with Peritoneal Dissemination after HIPEC , 2018, Annals of Surgical Oncology.

[2]  M. Milione,et al.  Correction to: Clinical Surveillance After Macroscopically Complete Surgery for Low-Grade Appendiceal Mucinous Neoplasms (LAMN) with or Without Limited Peritoneal Spread: Long-Term Results in a Prospective Series , 2018, Annals of Surgical Oncology.

[3]  R. Yantiss,et al.  The histopathological classification, diagnosis and differential diagnosis of mucinous appendiceal neoplasms, appendiceal adenocarcinomas and pseudomyxoma peritonei , 2017, Histopathology.

[4]  A. Lowy,et al.  Overinterpretation is common in pathological diagnosis of appendix cancer during patient referral for oncologic care , 2017, PloS one.

[5]  Ahmed Kamel,et al.  Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology. , 2017, Journal of the National Comprehensive Cancer Network : JNCCN.

[6]  Poonam K Sharma,et al.  Early identification of DPAM in at-risk low-grade appendiceal mucinous neoplasm patients: a new approach to surveillance for peritoneal metastasis , 2016, World Journal of Surgical Oncology.

[7]  R. Salazar,et al.  Recommendations in the management of epithelial appendiceal neoplasms and peritoneal dissemination from mucinous tumours (pseudomyxoma peritonei) , 2016, Clinical and Translational Oncology.

[8]  H. Birgisson,et al.  Importance of Absent Neoplastic Epithelium in Patients Treated With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy , 2016, Annals of Surgical Oncology.

[9]  L. Sobin,et al.  A Consensus for Classification and Pathologic Reporting of Pseudomyxoma Peritonei and Associated Appendiceal Neoplasia: The Results of the Peritoneal Surface Oncology Group International (PSOGI) Modified Delphi Process , 2016, The American journal of surgical pathology.

[10]  J. Misdraji.  Mucinous epithelial neoplasms of the appendix and pseudomyxoma peritonei , 2015, Modern Pathology.

[11]  M. Schwartz,et al.  Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with peritoneal hepatocellular carcinoma , 2014, Journal of surgical oncology.

[12]  Tae Won Kim,et al.  Comparison of recurrence patterns between ≤5 years and >5 years after curative operations in colorectal cancer patients , 2013, Journal of surgical oncology.

[13]  T. Chua,et al.  Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  S. Ahrendt,et al.  Aggressive Management of Peritoneal Carcinomatosis from Mucinous Appendiceal Neoplasms , 2012, Annals of Surgical Oncology.

[15]  J. Baek,et al.  A retrospective clinicopathological analysis of appendiceal tumors from 3,744 appendectomies: a single-institution study , 2011, International Journal of Colorectal Disease.

[16]  D. Bartlett,et al.  Surgical Techniques in Visceral Resection and Peritonectomy Procedures , 2009, Cancer journal.

[17]  P. Sugarbaker.  Epithelial Appendiceal Neoplasms , 2009, Cancer journal.

[18]  B. Moran,et al.  Consensus statement on the loco‐regional treatment of appendiceal mucinous neoplasms with peritoneal dissemination (pseudomyxoma peritonei) , 2008, Journal of surgical oncology.

[19]  M. V. van Velthuysen,et al.  Appendiceal neoplasms and pseudomyxoma peritonei: a population based study. , 2008, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[20]  M. O'donnell,et al.  Malignant neoplasms of the appendix , 2007, International Journal of Colorectal Disease.

[21]  S. Connor,et al.  Appendiceal tumors , 1998, Diseases of the colon and rectum.

[22]  R. Spence,et al.  Neoplastic lesions of the appendix , 1995, The British journal of surgery.

[23]  M. Milione,et al.  Clinical Surveillance After Macroscopically Complete Surgery for Low-Grade Appendiceal Mucinous Neoplasms (LAMN) with or Without Limited Peritoneal Spread: Long-Term Results in a Prospective Series , 2017, Annals of Surgical Oncology.

[24]  N. Petrelli,et al.  Consensus Guidelines from The American Society of Peritoneal Surface Malignancies on Standardizing the Delivery of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Colorectal Cancer Patients in the United States , 2013, Annals of Surgical Oncology.

[25]  P. Sugarbaker.  New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? , 2006, The Lancet. Oncology.

[26]  J. Cooper.  Ajcc Cancer Staging Manual , 1997 .

[27]  P. Sugarbaker,et al.  Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. , 1996, Cancer treatment and research.

[28]  M. Parker,et al.  World Journal of Surgical Oncology Open Access Pseudomyxoma Extraperitonei Occurring 35 Years after Appendicectomy: a Case Report and Review of Literature , 2022 .